113 related articles for article (PubMed ID: 15512950)
21. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
[TBL] [Abstract][Full Text] [Related]
22. [Macular edema after an uncomplicated cataract surgery].
Jurecka T; Bátková Z; Ventruba J
Cesk Slov Oftalmol; 2007 Jul; 63(4):262-73. PubMed ID: 17682606
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
24. Localization of blood-retinal barrier breakdown in human pathologic specimens by immunohistochemical staining for albumin.
Vinores SA; Campochiaro PA; Lee A; McGehee R; Gadegbeku C; Green WR
Lab Invest; 1990 Jun; 62(6):742-50. PubMed ID: 2193194
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates.
Ozaki H; Hayashi H; Vinores SA; Moromizato Y; Campochiaro PA; Oshima K
Exp Eye Res; 1997 Apr; 64(4):505-17. PubMed ID: 9227268
[TBL] [Abstract][Full Text] [Related]
26. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
[TBL] [Abstract][Full Text] [Related]
27. Blood-to-retina transport of creatine via creatine transporter (CRT) at the rat inner blood-retinal barrier.
Nakashima T; Tomi M; Katayama K; Tachikawa M; Watanabe M; Terasaki T; Hosoya K
J Neurochem; 2004 Jun; 89(6):1454-61. PubMed ID: 15189348
[TBL] [Abstract][Full Text] [Related]
28. Prophylaxis of aphakic cystoid macular edema using topical indomethacin.
Miyake K
J Am Intraocul Implant Soc; 1978 Oct; 4(4):174-9. PubMed ID: 748308
[TBL] [Abstract][Full Text] [Related]
29. Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy.
Luan H; Roberts R; Sniegowski M; Goebel DJ; Berkowitz BA
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):320-8. PubMed ID: 16384980
[TBL] [Abstract][Full Text] [Related]
30. Cationic amino acid transporter 1-mediated L-arginine transport at the inner blood-retinal barrier.
Tomi M; Kitade N; Hirose S; Yokota N; Akanuma S; Tachikawa M; Hosoya K
J Neurochem; 2009 Nov; 111(3):716-25. PubMed ID: 19712052
[TBL] [Abstract][Full Text] [Related]
31. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
Navaratna D; McGuire PG; Menicucci G; Das A
Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
[TBL] [Abstract][Full Text] [Related]
32. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244
[TBL] [Abstract][Full Text] [Related]
33. MRI retinovascular studies in humans: research in patients with diabetes.
Trick GL; Edwards PA; Desai U; Morton PE; Latif Z; Berkowitz BA
NMR Biomed; 2008 Nov; 21(9):1003-12. PubMed ID: 18821575
[TBL] [Abstract][Full Text] [Related]
34. Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine.
Hosoya K; Makihara A; Tsujikawa Y; Yoneyama D; Mori S; Terasaki T; Akanuma S; Tomi M; Tachikawa M
J Pharmacol Exp Ther; 2009 Apr; 329(1):87-93. PubMed ID: 19116370
[TBL] [Abstract][Full Text] [Related]
35. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
Vinten M; Larsen M; Lund-Andersen H; Sander B; La Cour M
Acta Ophthalmol Scand; 2007 Feb; 85(1):21-6. PubMed ID: 17244205
[TBL] [Abstract][Full Text] [Related]
36. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular oedema.
Vinores SA; Amin A; Derevjanik NL; Green WR; Campochiaro PA
Histochem J; 1994 Aug; 26(8):655-65. PubMed ID: 7982791
[TBL] [Abstract][Full Text] [Related]
38. [Effect of infrasound on ultrastructure and permeability of rat's blood-retinal barrier].
Qiu P; Zhang Z; Jiang Y; Gou Q; Wang B; Gou L; Chen J
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):499-501. PubMed ID: 12410992
[TBL] [Abstract][Full Text] [Related]
39. The RNA-binding protein Musashi-1 is produced in the developing and adult mouse eye.
Raji B; Dansault A; Leemput J; de la Houssaye G; Vieira V; Kobetz A; Arbogast L; Masson C; Menasche M; Abitbol M
Mol Vis; 2007 Aug; 13():1412-27. PubMed ID: 17768378
[TBL] [Abstract][Full Text] [Related]
40. Synergistic protective effects of escin and low‑dose glucocorticoids on blood‑retinal barrier breakdown in a rat model of retinal ischemia.
Zhang F; Li Y; Zhang L; Mu G
Mol Med Rep; 2013 May; 7(5):1511-5. PubMed ID: 23525122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
